Rep. Dennis M. Reboletti

Filed: 4/13/2011

 

 


 

 


 
09700HB2595ham002LRB097 07359 RLC 54482 a

1
AMENDMENT TO HOUSE BILL 2595

2    AMENDMENT NO. ______. Amend House Bill 2595 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 204 as follows:
 
6    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
7    Sec. 204. (a) The controlled substances listed in this
8Section are included in Schedule I.
9    (b) Unless specifically excepted or unless listed in
10another schedule, any of the following opiates, including their
11isomers, esters, ethers, salts, and salts of isomers, esters,
12and ethers, whenever the existence of such isomers, esters,
13ethers and salts is possible within the specific chemical
14designation:
15        (1) Acetylmethadol;
16        (1.1) Acetyl-alpha-methylfentanyl

 

 

09700HB2595ham002- 2 -LRB097 07359 RLC 54482 a

1    (N-[1-(1-methyl-2-phenethyl)-
2    4-piperidinyl]-N-phenylacetamide);
3        (2) Allylprodine;
4        (3) Alphacetylmethadol, except
5    levo-alphacetylmethadol (also known as levo-alpha-
6    acetylmethadol, levomethadyl acetate, or LAAM);
7        (4) Alphameprodine;
8        (5) Alphamethadol;
9        (6) Alpha-methylfentanyl
10    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
11    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
12    propanilido) piperidine;
13        (6.1) Alpha-methylthiofentanyl
14    (N-[1-methyl-2-(2-thienyl)ethyl-
15    4-piperidinyl]-N-phenylpropanamide);
16        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
17        (7.1) PEPAP
18    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
19        (8) Benzethidine;
20        (9) Betacetylmethadol;
21        (9.1) Beta-hydroxyfentanyl
22    (N-[1-(2-hydroxy-2-phenethyl)-
23    4-piperidinyl]-N-phenylpropanamide);
24        (10) Betameprodine;
25        (11) Betamethadol;
26        (12) Betaprodine;

 

 

09700HB2595ham002- 3 -LRB097 07359 RLC 54482 a

1        (13) Clonitazene;
2        (14) Dextromoramide;
3        (15) Diampromide;
4        (16) Diethylthiambutene;
5        (17) Difenoxin;
6        (18) Dimenoxadol;
7        (19) Dimepheptanol;
8        (20) Dimethylthiambutene;
9        (21) Dioxaphetylbutyrate;
10        (22) Dipipanone;
11        (23) Ethylmethylthiambutene;
12        (24) Etonitazene;
13        (25) Etoxeridine;
14        (26) Furethidine;
15        (27) Hydroxpethidine;
16        (28) Ketobemidone;
17        (29) Levomoramide;
18        (30) Levophenacylmorphan;
19        (31) 3-Methylfentanyl
20    (N-[3-methyl-1-(2-phenylethyl)-
21    4-piperidyl]-N-phenylpropanamide);
22        (31.1) 3-Methylthiofentanyl
23    (N-[(3-methyl-1-(2-thienyl)ethyl-
24    4-piperidinyl]-N-phenylpropanamide);
25        (32) Morpheridine;
26        (33) Noracymethadol;

 

 

09700HB2595ham002- 4 -LRB097 07359 RLC 54482 a

1        (34) Norlevorphanol;
2        (35) Normethadone;
3        (36) Norpipanone;
4        (36.1) Para-fluorofentanyl
5    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
6    4-piperidinyl]propanamide);
7        (37) Phenadoxone;
8        (38) Phenampromide;
9        (39) Phenomorphan;
10        (40) Phenoperidine;
11        (41) Piritramide;
12        (42) Proheptazine;
13        (43) Properidine;
14        (44) Propiram;
15        (45) Racemoramide;
16        (45.1) Thiofentanyl
17    (N-phenyl-N-[1-(2-thienyl)ethyl-
18    4-piperidinyl]-propanamide);
19        (46) Tilidine;
20        (47) Trimeperidine;
21        (48) Beta-hydroxy-3-methylfentanyl (other name:
22    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
23    N-phenylpropanamide).
24    (c) Unless specifically excepted or unless listed in
25another schedule, any of the following opium derivatives, its
26salts, isomers and salts of isomers, whenever the existence of

 

 

09700HB2595ham002- 5 -LRB097 07359 RLC 54482 a

1such salts, isomers and salts of isomers is possible within the
2specific chemical designation:
3        (1) Acetorphine;
4        (2) Acetyldihydrocodeine;
5        (3) Benzylmorphine;
6        (4) Codeine methylbromide;
7        (5) Codeine-N-Oxide;
8        (6) Cyprenorphine;
9        (7) Desomorphine;
10        (8) Diacetyldihydromorphine (Dihydroheroin);
11        (9) Dihydromorphine;
12        (10) Drotebanol;
13        (11) Etorphine (except hydrochloride salt);
14        (12) Heroin;
15        (13) Hydromorphinol;
16        (14) Methyldesorphine;
17        (15) Methyldihydromorphine;
18        (16) Morphine methylbromide;
19        (17) Morphine methylsulfonate;
20        (18) Morphine-N-Oxide;
21        (19) Myrophine;
22        (20) Nicocodeine;
23        (21) Nicomorphine;
24        (22) Normorphine;
25        (23) Pholcodine;
26        (24) Thebacon.

 

 

09700HB2595ham002- 6 -LRB097 07359 RLC 54482 a

1    (d) Unless specifically excepted or unless listed in
2another schedule, any material, compound, mixture, or
3preparation which contains any quantity of the following
4hallucinogenic substances, or which contains any of its salts,
5isomers and salts of isomers, whenever the existence of such
6salts, isomers, and salts of isomers is possible within the
7specific chemical designation (for the purposes of this
8paragraph only, the term "isomer" includes the optical,
9position and geometric isomers):
10        (1) 3,4-methylenedioxyamphetamine
11    (alpha-methyl,3,4-methylenedioxyphenethylamine,
12    methylenedioxyamphetamine, MDA);
13        (1.1) Alpha-ethyltryptamine
14    (some trade or other names: etryptamine;
15    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
16    3-(2-aminobutyl)indole; a-ET; and AET);
17        (2) 3,4-methylenedioxymethamphetamine (MDMA);
18        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
19    (also known as: N-ethyl-alpha-methyl-
20    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
21    and MDEA);
22        (2.2) N-Benzylpiperazine (BZP);
23        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
24        (4) 3,4,5-trimethoxyamphetamine (TMA);
25        (5) (Blank);
26        (6) Diethyltryptamine (DET);

 

 

09700HB2595ham002- 7 -LRB097 07359 RLC 54482 a

1        (7) Dimethyltryptamine (DMT);
2        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
3        (9) Ibogaine  (some trade and other names:
4    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
5    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
6    indole; Tabernanthe iboga);
7        (10) Lysergic acid diethylamide;
8        (10.5) Salvia divinorum (meaning all parts of the plant
9    presently classified botanically as Salvia divinorum,
10    whether growing or not, the seeds thereof, any extract from
11    any part of that plant, and every compound, manufacture,
12    salts, isomers, and salts of isomers whenever the existence
13    of such salts, isomers, and salts of isomers is possible
14    within the specific chemical designation, derivative,
15    mixture, or preparation of that plant, its seeds or
16    extracts);
17        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
18        (12) Peyote (meaning all parts of the plant presently
19    classified botanically as Lophophora williamsii Lemaire,
20    whether growing or not, the seeds thereof, any extract from
21    any part of that plant, and every compound, manufacture,
22    salts, derivative, mixture, or preparation of that plant,
23    its seeds or extracts);
24        (13) N-ethyl-3-piperidyl benzilate (JB 318);
25        (14) N-methyl-3-piperidyl benzilate;
26        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine

 

 

09700HB2595ham002- 8 -LRB097 07359 RLC 54482 a

1    (also known as N-hydroxy-alpha-methyl-
2    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
3        (15) Parahexyl; some trade or other names:
4    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
5    dibenzo (b,d) pyran; Synhexyl;
6        (16) Psilocybin;
7        (17) Psilocyn;
8        (18) Alpha-methyltryptamine (AMT);
9        (19) 2,5-dimethoxyamphetamine
10    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
11        (20) 4-bromo-2,5-dimethoxyamphetamine
12    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
13    4-bromo-2,5-DMA);
14        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
15    Some trade or other names: 2-(4-bromo-
16    2,5-dimethoxyphenyl)-1-aminoethane;
17    alpha-desmethyl DOB, 2CB, Nexus;
18        (21) 4-methoxyamphetamine
19    (4-methoxy-alpha-methylphenethylamine;
20    paramethoxyamphetamine; PMA);
21        (22) (Blank);
22        (23) Ethylamine analog of phencyclidine.
23    Some trade or other names:
24    N-ethyl-1-phenylcyclohexylamine,
25    (1-phenylcyclohexyl) ethylamine,
26    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;

 

 

09700HB2595ham002- 9 -LRB097 07359 RLC 54482 a

1        (24) Pyrrolidine analog of phencyclidine. Some trade
2    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
3    PHP;
4        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
5        (26) 2,5-dimethoxy-4-ethylamphetamine
6    (another name: DOET);
7        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
8    (another name: TCPy);
9        (28) (Blank);
10        (29) Thiophene analog of phencyclidine (some trade
11    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
12    2-thienyl analog of phencyclidine; TPCP; TCP);
13        (30) Bufotenine (some trade or other names:
14    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
15    3-(2-dimethylaminoethyl)-5-indolol;
16    5-hydroxy-N,N-dimethyltryptamine;
17    N,N-dimethylserotonin; mappine);
18        (31)  1-Pentyl-3-(1-naphthoyl)indole 
19    Some trade or other names: JWH-018; 
20        (32) 1-Butyl-3-(1-naphthoyl)indole 
21    Some trade or other names: JWH-073; . 
22        (33) Any compound structurally derived from 
23    3-(1-naphthoyl)indole or 1H-indol-3-yl- 
24    (1-naphthyl)methane by substitution at the 
25    nitrogen atom of the indole ring by alkyl, haloalkyl, 
26    alkenyl, cycloalkylmethyl, cycloalkylethyl or 

 

 

09700HB2595ham002- 10 -LRB097 07359 RLC 54482 a

1    2-(4-morpholinyl)ethyl whether or not further 
2    substituted in the indole ring to any extent, whether 
3    or not substituted in the naphthyl ring to any extent; 
4        (34) Any compound structurally derived from 
5    3-(1-naphthoyl)pyrrole by substitution at the nitrogen 
6    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 
7    cycloalkylmethyl, cycloalkylethyl or 2- 
8    (4-morpholinyl)ethyl, whether or not further 
9    substituted in the pyrrole ring to any extent, whether 
10    or not substituted in the naphthyl ring to any extent; 
11        (35) Any compound structurally derived from 
12    1-(1-naphthylmethyl)indene by substitution 
13    at the 3-position of the indene ring by alkyl, haloalkyl, 
14    alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- 
15    (4-morpholinyl)ethyl whether or not further 
16    substituted in the indene ring to any extent, whether 
17    or not substituted in the naphthyl ring to any extent; 
18        (36) Any compound structurally derived from 
19    3-phenylacetylindole by substitution at the 
20    nitrogen atom of the indole ring with alkyl, haloalkyl, 
21    alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- 
22    (4-morpholinyl)ethyl, whether or not further 
23    substituted in the indole ring to any extent, whether 
24    or not substituted in the phenyl ring to any extent; 
25        (37) Any compound structurally derived from 
26    2-(3-hydroxycyclohexyl)phenol by substitution 

 

 

09700HB2595ham002- 11 -LRB097 07359 RLC 54482 a

1    at the 5-position of the phenolic ring by alkyl, 
2    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl 
3    or 2-(4-morpholinyl)ethyl, whether or not substituted 
4    in the cyclohexyl ring to any extent. 
5    (e) Unless specifically excepted or unless listed in
6another schedule, any material, compound, mixture, or
7preparation which contains any quantity of the following
8substances having a depressant effect on the central nervous
9system, including its salts, isomers, and salts of isomers
10whenever the existence of such salts, isomers, and salts of
11isomers is possible within the specific chemical designation:
12        (1) mecloqualone;
13        (2) methaqualone; and
14        (3) gamma hydroxybutyric acid.
15    (f) Unless specifically excepted or unless listed in
16another schedule, any material, compound, mixture, or
17preparation which contains any quantity of the following
18substances having a stimulant effect on the central nervous
19system, including its salts, isomers, and salts of isomers:
20        (1) Fenethylline;
21        (2) N-ethylamphetamine;
22        (3) Aminorex (some other names:
23    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
24    4-5-dihydro-5-phenyl-2-oxazolamine) and its
25    salts, optical isomers, and salts of optical isomers;
26        (4) Methcathinone (some other names:

 

 

09700HB2595ham002- 12 -LRB097 07359 RLC 54482 a

1    2-methylamino-1-phenylpropan-1-one;
2    Ephedrone; 2-(methylamino)-propiophenone;
3    alpha-(methylamino)propiophenone; N-methylcathinone;
4    methycathinone; Monomethylpropion; UR 1431) and its
5    salts, optical isomers, and salts of optical isomers;
6        (5) Cathinone (some trade or other names:
7    2-aminopropiophenone; alpha-aminopropiophenone;
8    2-amino-1-phenyl-propanone; norephedrone);
9        (6) N,N-dimethylamphetamine (also known as:
10    N,N-alpha-trimethyl-benzeneethanamine;
11    N,N-alpha-trimethylphenethylamine);
12        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
13    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
14    (g) Temporary listing of substances subject to emergency
15scheduling. Any material, compound, mixture, or preparation
16that contains any quantity of the following substances:
17        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
18    (benzylfentanyl), its optical isomers, isomers, salts,
19    and salts of isomers;
20        (2) N-[1(2-thienyl)
21   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
22   its optical isomers, salts, and salts of isomers.
23(Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07;
2496-347, eff. 1-1-10; 96-1285, eff. 1-1-11.)".